Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer

Clinical trial NCT00357760 · COMPLETED

Trial details

NCT number: NCT00357760
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Renal Cell Carcinoma

Start date: 2007-12-01
Primary completion: 2015-10-01
Enrollment: 94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.